Tag: prescription drugs

21 Jun 2017
img

The Brussels Principles underscore the importance of the international online marketplace as a lifeline of affordable medication for the millions of people forced to go without necessary treatment due to drug cost and availability.

On March 31st, 2017, Prescription Justice organized a panel for the RightsCon 2017 conference in Brussels, which addressed protecting online access to safe and affordable medication. The organizers of RightsCon just published their outcomes document in which Prescription Justice’s effort to bring together both medicines access and Internet freedom advocates was recognized.

At that conference, the participants discussed a set of draft principles pertaining to medication sales over the Internet and prescription drug importation. The prevailing position among the panelists was that initiatives funded by the pharmaceutical industry that affect access to medicines on the Internet were detrimental to the cause of prescription drug affordability.

(more…)

08 May 2017
img

While the intense focus in Congress last week was the passage of the American Healthcare Act, millions of Americans continue to struggle with the cost of prescription medications. In 2016, 45 million Americans did not fill a prescription because of cost, and a recent poll commissioned by Prescription Justice shows that 75% Americans agree with President Trump that they drug companies are getting away with murder.

Not just individual patients but federal and state governments face an uphill budget battle as well. Public programs like Medicare, Medicaid and the Department of Veteran's Affairs continue to grapple with dramatic price increases that are crippling their budgets.

Congress has introduced several bills in 2017 to address the crisis of high drug prices. Here’s a summary:

Improving Access to Affordable Prescription Drugs Act (HR 1776/S. 771)

On March 29, S. 771, The Improving Access to Affordable Prescription Drugs Act (Act), was introduced by Senator Al Franken (D-MN) and fifteen Democratic co-sponsors.  A companion bill (HR 1776) was also introduced in the House by Representative Jan Schakowsky (D-IL) with four Democratic co-sponsors.

(more…)

19 Apr 2017
img

Prescription Justice’s president, Gabriel Levitt, organized a dynamic panel session to discuss the importance of online access to safe and affordable medicines at the RightsCon conference last month in Brussels, Belgium. Created and organized by Access Now, since 2011, RightsCon has become one of the world’s leading events covering the implications of the Internet on society. This past conference, it’s largest ever, brought together 1500 people from 100 countries, including human rights experts and activists, business leaders, technologists, engineers, investors, activists and government representatives; most who are there to promote an open Internet and digital rights globally. (more…)

14 Mar 2017
img

The U.S. Centers for Disease Control and Prevention (CDC) - Public Health Grand Rounds – recently hosted a webinar on “Overcoming Barriers to Medication Adherence for Chronic Diseases.”  The event brought together a panel of leaders in pharmacy, nursing, medicine, academia, and public health to discuss the burden of medication nonadherence and barriers for adherence among patients with chronic diseases—including HIV/AIDS.

Medication nonadherence manifests in two distinct behaviors: intentional, such as choosing to forgo filling a prescription because of cost, or unintentional, where patients simply forget to take their medication or are unable to manage multiple medications or complex treatment regimens. The panelists highlighted how intervention strategies aimed at medication adherence can positively affect patient health outcomes. (more…)

28 Feb 2017
img

"By introducing the Affordable and Safe Prescription Drug Importation Act, Sens. Sanders, Booker and Casey have heeded the call of the millions of Americans who struggle each year with the insurmountable costs of prescription drugs " said Jodi Dart, executive director of Prescription Justice. "This legislation will provide new safety protocols and guidance for American consumers who need access to lower cost medications from safe international pharmacies, beginning with Canada.  Last year, 45 million Americans did not fill a prescription because of costs, and a recent poll commissioned by Prescription Justice shows overwhelming majorities support changes that will bring down drug prices. President Trump and members of Congress have an opportunity to make good on their promises to lower drug prices for American consumers. We hope they will have the political will and courage to pass this important legislation."

Prescription Justice is a non-profit organization that brings together doctors, lawyers, public health advocates, and companies dedicated to helping people afford medication. Prescription Justice advocates for legislative and policy reforms to allow personal prescription importation, permitting Medicare to negotiate drug prices, and ending "pay to delay" activities by pharmaceutical companies that prevent lower cost generics from coming to market.

06 Feb 2017
img

Today, Prescription Justice issued a press release announcing new data showing that 45 million Americans did not fill a prescription in 2016 because of drug costs and the publication of its policy report recommending that President Donald Trump take executive actions to help consumers more easily import lower cost medications for personal use. Previously, Prescription Justice reported that 35 million American adults did not fill a prescription because of cost. The new data, extracted from the Commonwealth Fund’s 2016 International Health Policy Survey of Adults, shows the crisis of high drug prices to be worse than is widely reported. (more…)

30 Jan 2017
img

We are proud to announce that we have changed our organization's (DBA) name from Prescription Justice Action Group to Prescription Justice, which is a simpler expression of our core position: making prescription drugs affordable is an issue of justice for Americans and we will help them obtain it.

In addition to our website and logo redesign, we have also added a weekly media update that features top news and journal articles focused on our policy priorities - personal drug importation, Medicare Drug Price Negotiations, and ending "Pay for Delay", - as well as other advocacy efforts about tackling the prescription drug price crisis in America and globally.

Let's all work together to bring about prescription justice!

21 Jan 2017
img

Last week, Senators Bernie Sanders (I-VT) and Amy Klobuchar (D-MN) proposed an amendment (S.A. 178) to the Senate Budget Reconciliation bill that would allow individuals, pharmacies and wholesalers to import prescription medications from Canada and other countries with a valid prescription from a U.S. provider.

The amendment took place during a 7-hour vote-a-rama in which more than 150 amendments were considered and voted on for a brief ten minutes.  The amendment failed 52-46, with 13 Democrats voting against it. While the measure failed to pass, it surprisingly garnered support from 12 Republicans including Senators Ted Cruz and Rand Paul. It’s worth noting that Senators Chuck Schumer (D-NY) and Kristen Gillibrand (D-NY) voted against the Dorgan-Snowe importation amendment in 2009, voted yes this time around. (more…)

06 Jan 2017
img

Value-based pharmaceutical pricing, aimed at achieving better value for pharmaceutical spending and lowering drug prices, while maintaining innovation, is a concept that is gaining traction.  In the U.S., prescription drug prices are set by pharmaceutical companies to maximize profits, not based on how well a drug works. In contrast, according to its proponents, value-based drug pricing would mean real health outcomes (not just profits) determine the cost of a drug.  

President-Elect Trump’s push for healthcare reform that focuses on free market, consumer-driven initiatives will enhance the political viability of value-based drug pricing. It has more support by the pharmaceutical industry than other popular policies to bring down drug prices, as it’s viewed as more in line with free market principles than other policy proposals, such as allowing Medicare to negotiate drug prices. 

(more…)

12 Dec 2016
img

The pharmaceutical industry often defends shameful price gouging of consumers by arguing that their high profits fund the research and development of tomorrow’s new miracle cures. There is robust debate about the degree to which lowering drug prices would hurt pharmaceutical innovation. The current system holds consumers and governments hostage to pharmaceutical company business models in a manner that is inherently unethical. Think of the cancer patient who has to shell out $30,000 in co-insurance to live, and if not, then die.

The concept and practice of “delinkage,” in which the invention of new medicines is delinked from high drug prices transcends this old debate and envisions a brighter more humane future…one with robust pharmaceutical innovation.

(more…)